is bpc 157 local or systemic Stable Gastric Pentadecapeptide as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System Examples of successful administration mechanisms

Cardiovascular Studies Cardiac Protection Research has demonstrated BPC-157's potential cardioprotective effects [21]: Protection against arrhythmias induced by various drugs Improved cardiac function after ischemic injury Enhanced coronary blood flow Reduced infarct size in heart attack models Blood Vessel Effects Studies on blood vessel healing show BPC-157 promotes: Arterial healing after injury Venous healing and reduced thrombosis Collateral vessel development Endothelial function improvement Benefits by Category with Evidence Ratings Gut Healing Strong Evidence Evidence Rating: Strong (Multiple animal studies, consistent results) The gastrointestinal applications of BPC-157 have the most robust research support: Ulcer healing (gastric and duodenal) NSAID-induced damage protection and reversal Inflammatory bowel conditions Intestinal permeability ("leaky gut") Esophageal damage healing Liver protection The consistency of results across multiple studies and various injury models provides strong preclinical evidence

Legality: Compounding from bulk substances that arent on the FDAs approved list may violate Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act, exposing providers to enforcement risk

Maybe just a fraction of each dose

It has no licensed medical indication in the UK

It first drew research interest for its ability to heal stomach ulcers and inflammatory bowel conditions, then expanded to tendon, ligament, muscle, and even bone healing across dozens of preclinical studies (Sikiric et al., PubMed)